Anti-angiogenic polypeptides A61 or p22 are disclosed. Also disclosed are methods of making the polypeptides and methods of treating subjects having angiogenic diseases or conditions.
Edits on 26 May, 2023
"Remove website redirecting to Patent Public Search front page"